Saqib Islam
CIK 1575408 · Chief Executive Officer · last filed 2026-06-26
Saqib Islam is a Chief Executive Officer who has filed 54 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for SPRY, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$31.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.1K
4
54
-$31.12M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRY | Director | — | $5.67 | — | $0 | 4 | 2026-06-26 |
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Chief Executive Officer | 0 | $46.99 | $0 | -$31.21M | 25 | 2025-07-02 |
| PASG | Director | 250 | $4.57 | $1.1K | $90.0K | 7 | 2025-05-30 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | — | $5.87 | — | $0 | 3 | 2022-06-13 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-26 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2025-07-02 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Disp (D) | −954,869 | $0 | EDGAR |
| 2025-06-27 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2025-05-30 | PASG | Grant (A) | — | $0 | EDGAR |
| 2025-03-05 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | −79,756 | -$4.30M | EDGAR |
| 2025-02-24 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −29,328 | -$1.77M | EDGAR |
| 2025-02-19 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −10,672 | -$639.5K | EDGAR |
| 2025-02-14 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | +72,123 | -$781.7K | EDGAR |
| 2025-02-12 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −48,000 | -$2.56M | EDGAR |
| 2025-02-10 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Notice (144) | −137,000 | -$7.30M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.